Have a personal or library account? Click to login
Microemulsions as the Potential Delivery System for Nimodipine Cover

Microemulsions as the Potential Delivery System for Nimodipine

Open Access
|Aug 2023

References

  1. Heran L., Haiting L., Chen W. et al. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine. Eur J Pharm Sci. 2018; 117:321–330.
  2. Huang Y., Zhang S., Shen H., Jinqing L., Chongkai G. Controlled release of the nimodipine-loaded self microemulsion osmotic pump capsules: development and characterization. AAPS PharmSciTech. 2018; 19:1308–1319.
  3. Kiwilsza A., Milanowski B., Druzbicki K. et al. Mesoporous drug carrier systems for enhanced delivery rate of poorly water-soluble drug: nimodipine. J Porous Mater. 2015; 22:817–829.
  4. Lee Y.H., Kim D., Ko B.H. et al. Improved aqueous dissolution of nimodipine using self-micro emulsifying solid compositions. Acta Pol. Pharm. 2021; 78:427–436.
  5. Mohamed M.M. J., Khan B. A., Rajendrand V. et al. Polymeric ethosomal gel loaded with nimodipine: Optimisation, pharmacokinetic and histopathological analysis. Saudi Pharm J. 2022; 30:1603–1611.
  6. Pathak R., Dash R.P., Misra M., Nivsarkar M. Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route. Acta Pharm Sin B. 2014; 4:151–160.
  7. Wang Z., Deng Y., Zhang X., Wang T., Wu F. Development and pharmacokinetics of nimodipine-loaded liposomes. J Pharm Pharmacol. 2006; 58:1289–1294.
Language: English
Page range: 34 - 36
Submitted on: Jun 20, 2023
Accepted on: Jun 22, 2023
Published on: Aug 24, 2023
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2023 M. Čuchorová, M. Špaglová, M. Papadakos, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.